Clinical trials
Hypertension, Pulmonary trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 3 |
| 2009 | 4 |
| 2011 | 1 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Active, not recruiting | 6 |
| Terminated | 4 |
| Unknown status | 3 |
| Recruiting | 3 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 1 |
| No longer available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 10 |
| Istanbul University | 3 |
| Actelion | 2 |
| Dokuz Eylul University | 2 |
| Gazi University | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Pfizer | 2 |
| Saglik Bilimleri Universitesi | 2 |
| United Therapeutics | 2 |
| Acibadem University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension, Pulmonary | 39 |
| Pulmonary Arterial Hypertension | 12 |
| Cardiovascular Diseases | 3 |
| Lung Diseases | 3 |
| Vascular Diseases | 3 |
| Connective Tissue Diseases | 2 |
| Familial Primary Pulmonary Hypertension | 2 |
| Hypertension | 2 |
| Lung Diseases, Interstitial | 2 |
| Respiratory Tract Diseases | 2 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.